Vivoryon Therapeutics Nv (0R3M)
LSE
News
Market Data
Register to chat with like-minded investors on our interactive forums.
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 44k | 0 | 1,000 | 14k | 6k | 10.76M | 0 | -3.62M |
| Operating Income | -14.56M | -8.77M | -7.64M | -9.67M | -16.01M | -12.8M | -29.11M | -28.84M |
| Pre Tax Income | -14.51M | -8.83M | -7.7M | -9.75M | -16.51M | -12.22M | -28.36M | -28.58M |
| Net Income | -14.51M | -7.73M | -7.7M | -9.75M | -16.51M | -12.66M | -28.16M | -28.34M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -1.773 | -0.942 | -0.938 | -0.792 | -0.827 | -0.631 | -1.168 | -1.087 |
| EBIT | -14.56M | -8.77M | -7.64M | -9.67M | -16.01M | -12.8M | -29.11M | -28.84M |
| EBITDA | -14.46M | -8.66M | -7.61M | -9.64M | -15.87M | -12.63M | -28.99M | -28.72M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
